Skip to main navigation Skip to search Skip to main content

Do patents prevent access to drugs for HIV in developing countries?

  • Marleen Boelaert
  • , Lut Lynen
  • , Wim van Damme
  • , Robert Colebunders
  • , Eric Goemaere
  • , Anne Valerie Kaninda
  • , Laura Ciaffi
  • , Maryline Mulemba
  • , Ellen ’T Hoen
  • , Bernard Pécoul
  • , Michael J. Selgelid
  • , Udo Schuklenk
  • , Amir Attaran
  • , Lee Gillespie-White

Research output: Contribution to journalLetterResearchpeer-review

Original languageEnglish
Pages (from-to)840-843
Number of pages4
JournalJAMA
Volume287
Issue number7
DOIs
Publication statusPublished - 20 Feb 2002
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Africa
  • Antihiv agents
  • Antiretroviral therapy, highly active
  • Costs and cost analysis
  • Developing countries
  • Drug costs
  • Drug industry
  • Highly active antiretroviral therapy
  • HIV infections
  • Patents

Cite this